153 related articles for article (PubMed ID: 3978636)
21. Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: pharmacokinetic and structure-activity considerations.
Wong KH; Wallen CA; Wheeler KT
Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1043-50. PubMed ID: 2140824
[TBL] [Abstract][Full Text] [Related]
22. Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse.
Honess DJ; Workman P; Morgan JE; Bleehen NM
Br J Cancer; 1980 Apr; 41(4):529-40. PubMed ID: 7387851
[TBL] [Abstract][Full Text] [Related]
23. Concurrent measurements of blood flow and transcapillary transport in avian sarcoma virus-induced experimental brain tumors: implications for chemotherapy.
Blasberg R; Molnar P; Groothius D; Patlak C; Owens E; Fenstermacher J
J Pharmacol Exp Ther; 1984 Dec; 231(3):724-35. PubMed ID: 6094798
[TBL] [Abstract][Full Text] [Related]
24. Nonlinear pharmacokinetics of misonidazole and desmethylmisonidazole in the isolated perfused rat liver.
McManus ME; Monks A; Collins JM; White R; Strong JM
J Pharmacol Exp Ther; 1981 Dec; 219(3):669-74. PubMed ID: 7299690
[TBL] [Abstract][Full Text] [Related]
25. [Relation between distribution of DNA synthesizing cells and blood flow and glucose metabolism in Rous sarcoma virus-induced rat brain tumors].
Watanabe A
No To Shinkei; 1988 Jul; 40(7):637-45. PubMed ID: 2852019
[TBL] [Abstract][Full Text] [Related]
26. In vivo cytotoxicity of misonidazole and hyperthermia in a transplanted mouse mammary tumor.
Lehman CM; Stewart JR
Radiat Res; 1983 Dec; 96(3):628-34. PubMed ID: 6657927
[TBL] [Abstract][Full Text] [Related]
27. Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues.
Tozer GM; Prise VE; Wilson J; Locke RJ; Vojnovic B; Stratford MR; Dennis MF; Chaplin DJ
Cancer Res; 1999 Apr; 59(7):1626-34. PubMed ID: 10197639
[TBL] [Abstract][Full Text] [Related]
28. Distribution and tumor penetration properties of a radiosensitizer 2-[14C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography.
Akel G; Benard P; Canal P; Soula G
Cancer Chemother Pharmacol; 1986; 17(2):121-6. PubMed ID: 3719893
[TBL] [Abstract][Full Text] [Related]
29. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
Lee FY; Workman P
Br J Cancer; 1983 May; 47(5):659-69. PubMed ID: 6849803
[TBL] [Abstract][Full Text] [Related]
30. Effect of local hyperthermia on blood flow and microenvironment: a review.
Song CW
Cancer Res; 1984 Oct; 44(10 Suppl):4721s-4730s. PubMed ID: 6467226
[TBL] [Abstract][Full Text] [Related]
31. Effects of cimetidine, antipyrine, and pregnenolone carbonitrile on misonidazole pharmacokinetics.
Workman P; Donaldson J; Smith NC
Cancer Treat Rep; 1983; 67(7-8):723-5. PubMed ID: 6871889
[TBL] [Abstract][Full Text] [Related]
32. Regional blood flow in ethylnitrosourea-induced brain tumors.
Blasberg RG; Kobayashi T; Horowitz M; Rice JM; Groothuis D; Molnar P; Fenstermacher JD
Ann Neurol; 1983 Aug; 14(2):189-201. PubMed ID: 6625536
[TBL] [Abstract][Full Text] [Related]
33. Effect of partition coefficient on the ability of nitroimidazoles to enhance the cytotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Hirst DG; Brown JM; Hazlehurst JL
Cancer Res; 1983 May; 43(5):1961-5. PubMed ID: 6682009
[TBL] [Abstract][Full Text] [Related]
34. Tissue distribution of 14C- and 3H-labelled misonidazole in the tumor-bearing mouse.
Cobb LM; Nolan J; Butler S
Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):347-51. PubMed ID: 2303365
[TBL] [Abstract][Full Text] [Related]
35. Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole.
Varghese AJ; Whitmore GF
Cancer Res; 1980 Jul; 40(7):2165-9. PubMed ID: 6155991
[TBL] [Abstract][Full Text] [Related]
36. Binding of misonidazole to V79 spheroids and fragments of Dunning rat prostatic and human colon carcinomas in vitro: diffusion of oxygen and reactive metabolites.
Franko AJ; Koch CJ
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1333-6. PubMed ID: 6469756
[TBL] [Abstract][Full Text] [Related]
37. Metabolism and excretion of [3H]misonidazole by hypoxic rat liver.
Smith BR; Born JL
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1365-70. PubMed ID: 6469758
[TBL] [Abstract][Full Text] [Related]
38. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
Milas L; Ito H; Hunter N
Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
[TBL] [Abstract][Full Text] [Related]
39. Enhanced misonidazole binding in the presence of AF-2.
Olive PL
Radiat Res; 1987 Mar; 109(3):490-9. PubMed ID: 3562787
[TBL] [Abstract][Full Text] [Related]
40. Effect of oxygen on misonidazole chemosensitization and cytotoxicity in vitro.
Mulcahy RT
Cancer Res; 1984 Oct; 44(10):4409-13. PubMed ID: 6467202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
